Lynparza, a targeted cancer treatment, is classified as a PARP (or Poly ADP-ribose polymerase) inhibitor. PARP inhibitors like Lynparza generally do not cause hair loss. Hair loss has not been reported as a side effect of Lynparza in the package insert and clinical studies conducted by the manufacturer.